InMed Pharmaceuticals Inc (INM)
0.2268
-0.02
(-6.67%)
USD |
NASDAQ |
Nov 05, 16:00
0.2268
0.00 (0.00%)
After-Hours: 18:53
InMed Pharmaceuticals Gross Profit Margin (Quarterly): 36.32% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 36.32% |
| March 31, 2024 | 24.69% |
| December 31, 2023 | 26.14% |
| September 30, 2023 | 2.36% |
| June 30, 2023 | 67.95% |
| March 31, 2023 | 18.62% |
| December 31, 2022 | 27.92% |
| September 30, 2022 | -153.1% |
| June 30, 2022 | 48.51% |
| March 31, 2022 | 58.88% |
| December 31, 2021 | 42.08% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-153.1%
Minimum
Sep 2022
67.95%
Maximum
Jun 2023
18.22%
Average
27.92%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| Rimrock Gold Corp | -- |
| CeCors Inc | -- |
| Venus Concept Inc | 71.46% |
| Grace Therapeutics Inc | -- |
| Aurinia Pharmaceuticals Inc | 84.42% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.10% |
| Return on Assets | -58.63% |
| Return on Invested Capital | -70.10% |
| Profit Margin (Quarterly) | -151.0% |
| Operating Margin (Quarterly) | -156.6% |
| Return on Net Operating Assets | -174.0% |